Technical Analysis for DRRX - DURECT Corporation

Grade Last Price % Change Price Change
grade F 0.58 -3.33% -0.02
DRRX closed down 3.33 percent on Friday, January 18, 2019, on 1.12 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical DRRX trend table...

Date Alert Name Type % Chg
Jan 18 20 DMA Support Bullish 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Down 3 Days in a Row Weakness 0.00%
Jan 17 Narrow Range Bar Range Contraction -3.33%
Jan 17 Wide Bands Range Expansion -3.33%
Jan 16 Shooting Star Candlestick Bearish -7.50%
Jan 16 Lizard Bearish Bearish Day Trade Setup -7.50%
Jan 16 Doji - Bearish? Reversal -7.50%
Jan 16 Wide Bands Range Expansion -7.50%
Jan 16 Upper Bollinger Band Touch Strength -7.50%

Older signals for DRRX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
DURECT Corporation, a specialty pharmaceutical company, develops pharmaceutical systems technologies based on its proprietary drug delivery technology platforms. It focuses on the development of products for the treatment of various chronic and episodic disease areas, such as pain, central nervous system disorders, cardiovascular disease, and other chronic diseases. The company manufactures and sells ALZET osmotic pumps used in laboratory research; and a range of LACTEL standard and custom biodegradable polymers and excipients used as raw materials for the pharmaceutical and medical device clients. Its product pipeline includes REMOXY, an oral oxycodone gelatin capsule for chronic pain, which has received complete response letter from the U.S. Food and Drug Administration (FDA); POSIDUR, a Phase III clinical trial release formulation of bupivacaine for the treatment of post-surgical pain; ELADUR, a Phase II transdermal bupivacaine patch intended to provide delivery of bupivacaine; and TRANSDUR, a Phase II transdermal sufentanil patch intended to provide delivery of sufentanil. The company's products pipeline also comprises ORADUR-based opioids, including hydrocodone and hydromorphone for the treatment of pain, which are in Phase I clinical trial; oxymorphone, an ORADUR-based opioid for which IND has been accepted by the FDA; ORADUR-ADHD, a drug candidate in Phase I clinical trial for the treatment of attention deficit hyperactivity disorder; and Relday, an injectable risperidone product in Phase I clinical trial used to treat the symptoms of schizophrenia and bipolar I disorder. It is also involved in developing various biologics programs/research programs in other therapeutic categories. DURECT Corporation has strategic agreements with Hospira, Inc., Nycomed Danmark ApS; Pain Therapeutics, Inc.; Zogenix, Inc.; and Pfizer Inc. The company was founded in 1998 and is headquartered in Cupertino, California.
Is DRRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.55
52 Week Low 0.46
Average Volume 438,391
200-Day Moving Average 1.3646
50-Day Moving Average 0.7265
20-Day Moving Average 0.5716
10-Day Moving Average 0.6058
Average True Range 0.0617
ADX 21.94
+DI 20.7112
-DI 19.5529
Chandelier Exit (Long, 3 ATRs ) 0.5099
Chandelier Exit (Short, 3 ATRs ) 0.6451
Upper Bollinger Band 0.6738
Lower Bollinger Band 0.4694
Percent B (%b) 0.54
BandWidth 35.759272
MACD Line -0.0301
MACD Signal Line -0.0449
MACD Histogram 0.0148
Fundamentals Value
Market Cap 85.26 Million
Num Shares 147 Million
EPS -0.26
Price-to-Earnings (P/E) Ratio -2.23
Price-to-Sales 7.10
Price-to-Book 0.00
PEG Ratio -0.16
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.66
Resistance 3 (R3) 0.66 0.64 0.64
Resistance 2 (R2) 0.64 0.62 0.64 0.64
Resistance 1 (R1) 0.61 0.61 0.60 0.61 0.63
Pivot Point 0.59 0.59 0.59 0.59 0.59
Support 1 (S1) 0.56 0.57 0.55 0.56 0.53
Support 2 (S2) 0.54 0.56 0.54 0.52
Support 3 (S3) 0.51 0.54 0.52
Support 4 (S4) 0.51